01.03.2023 | Case report
Heparin/rivaroxaban
Major, non-major bleeding following off-label use and lack of efficacy: 13 case reports
Erschienen in: Reactions Weekly | Ausgabe 1/2023
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event